תבנית:תרופה/גאטקס - Gattex

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	A16AX Various alimentary tract and metabolism products
××¨××× ×¤×¢×× (ATC5)	Â Teduglutide 5 MG/VIAL âA16AX08
×¦××¨×ª ××ª×	×ª×ª-×¢××¨× - S.C
×¦××¨×ª ××× ××	×××§× ×××× ×ª ×ª×××¡× ×××¨××§×, POWDER FOR SOLUTION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Gattex is indicated for the treatment of patients aged 1 year and above with Short Bowel Syndrome. Patients should be stable following a period of intestinal adaptation after surgery.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/××××§×¡ - Gattex
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 29.05.2023 ××××¨× ××¢××× ××¨××¤× 14.03.2018 ××××¨×ª ××××¢ ××××××ª× ××¦×××ª ××¨×¤××× ×× ××××ª 16.12.2021 Â ××××¨× ××¢××× 29.05.2023

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 29.05.2023 ×¢××× ××¦×¨×× ×× ××××ª Patient information leaflet â31.05.2023 ×¢××× ××¦×¨×× ×¢×¨×××ª ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.05.2023 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×× ××××ª 16.12.2021 ××××¨×ª ××××¢ ××××××ª× ×××××¤×/×××¨× ××××¤×/×××¤× ×¢××§×¨× ×¢××¨××ª 16.12.2021

×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××××§×¡ ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	SHIRE NPS PHARMACEUTICALS INC., USA
×©× ××¢× ××¨××©××	NEOPHARM LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 07/2013. ×¨××©××× ××ª××¨××: 08/2014
×ª××¨×× ×¢×××× ×××¨××	14/05/19

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/××××§×¡ - Gattex}}

×:

{{×ª×¨××¤×/××××§×¡ - Gattex
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־26 בדצמבר 2023 ב־15:47

ויקיתרופות